Purchase Order 36C26219P1677
Award Date 7/24/19
Potential Completion Date 9/25/20
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85085, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $55,205.54 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the VA Baltimore Medical Center. The contract has a performance period through June 30, 2025. This requirement was competed on a full and open basis, without any set-aside designations. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, has...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $1,283,466.63 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for patient-specific chemotherapy compounding services. Avella, a subsidiary of UnitedHealth Group Incorporated, will provide specialized pharmacy services to support VA oncology and infusion treatment programs nationwide. The award is not associated with a set-aside designation. Avella has...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $1,875,405.34 contract is for the provision of compounded chemotherapy drugs to support VA oncology and infusion treatment programs at the VA Long Beach Healthcare System in California. The contract period of performance is April 2, 2019 to...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $976,800.00 firm-fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the emergency compounding of hazardous chemotherapy drugs. The order was awarded on November 27, 2018 with a performance period through January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, provides specialized pharmacy services to support VA oncology and infusion...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $699,995.00 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the provision of emergency compounded chemotherapy drugs. The period of performance was from February 1, 2019 to April 30, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, has received numerous VA-VHA awards to provide specialized pharmacy services involving chemotherapy and...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA) awarded a $900,000 firm fixed price blanket purchase agreement call contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, doing business as UnitedHealth Group. The contract is for chemotherapy compounding services to be performed in Phoenix, Arizona between November 2021 and November 2026.</p>
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $243,017.86 contract is for the provision of compounded chemotherapy and other hazardous sterile pharmaceutical preparations to support oncology and infusion treatment for veterans. The contract was awarded on a sole source basis through a...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. This BPA call, valued at $500,000.00, is for the renewal of a contract to provide chemotherapy compounding services over a one-year period of performance ending on November 16, 2023. Avella will perform the work at its own facilities to support VA...
- The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $216,982.32 firm fixed-price definitive contract for compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, which has no set-aside designation, was awarded on December 26, 2019 with a completion date of December 25, 2020. As the prime contractor, Avella Specialty Pharmacy will provide specialized...